Showing 201 - 220 results of 2,138 for search '"Chronic Myeloid Leukemia"', query time: 0.31s Refine Results
  1. 201
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206

    Treatment of chronic myeloid leukemia in rural Rwanda: promising early outcomes by Tapela, N, Nzayisenga, I, Sethi, R, Bigirimana, JB, Habineza, H, Hategekimana, V, Mantini, N, Mpunga, T, Shulman, LN, Lehmann, L

    Published 2016
    “…Although management of chronic myeloid leukemia (CML) has been described in low- and middle-income countries, few programs involve patients treated in rural settings. …”
    Journal article
  7. 207
  8. 208
  9. 209
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214

    Patterns of chromosome abnormalities in a sample of Colombian patients with chronic myeloid leukemia by Azucena Largo-Peralta, Milena Rondón-Lagos, Diana Sánchez-Peñarete, Katherin Cordón, Cladelis Rubio, Maribel Forero-Castro

    Published 2023-12-01
    “…Chronic Myeloid Leukemia (CML) is characterized by the presence of the Philadelphia (Ph) chromosome, resulting from a translocation between chromosomes 9 and 22 that gives rise to the BCR-ABL1 fusion gene. …”
    Get full text
    Article
  15. 215

    Acquired Factor VII Deficiency Associated With Chronic Myeloid Leukemia Blast Crisis by Emily B. Wolf MD, David Li MD, Andre J. Fernandez MPAS, PA-C, Lindsay B. Gardner MD, Candido E. Rivera MD, Ewa M. Wysokinska MD, Marwan E. Shaikh MD, Han W. Tun MD, Vivek Roy MD, Muhamad Alhaj Moustafa MD

    Published 2023-11-01
    “…We report a case of acquired FVII deficiency in a patient with recurrent chronic myeloid leukemia in blast crisis who developed bilateral retinal hemorrhages. …”
    Get full text
    Article
  16. 216

    TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN by Qiang Qiu, Yuanyuan Sun, Linyu Yang, Qingqing Li, Yunyu Feng, Mengyuan Li, Yuexia Yin, Li Zheng, Ning Li, Huandi Qiu, Xue Cui, Wei He, Bochuan Wang, Cong Pan, Zi Wang, Juan Huang, Klarke M. Sample, Zhihui Li, Yiguo Hu

    Published 2023-03-01
    “…LSCs represent an obstacle for chronic myeloid leukemia (CML) elimination, which continually replenish leukemia cells and are associated with disease relapse. …”
    Get full text
    Article
  17. 217
  18. 218

    Long-term outcomes of frontline imatinib therapy for chronic myeloid leukemia in China by Fang Cheng, Fang Cheng, Fang Cheng, Guolin Yuan, Qiang Li, Qiang Li, Zheng Cui, Zheng Cui, Weiming Li

    Published 2023-05-01
    “…BackgroundImatinib is the first-line therapy recommended for chronic myeloid leukemia (CML) patients in China. We reported a long-term follow-up study of patients on imatinib as first-line treatment for chronic phase (CP) CML to provide an important reference for the actual clinical treatment regimen of CML patients in China.MethodsWe evaluated the long-term efficacy, safety, low-dose attempt after years of treatment, and treatment-free remission (TFR) of 237 CML-CP patients receiving first-line imatinib therapy.ResultsThe median age was 46 years (interquartile range: 33–55). …”
    Get full text
    Article
  19. 219
  20. 220